Mary Ann Mascelli
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 7
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis 7
- Hematology top 1%
- Platelet Disorders and Treatments 14
-
- Acute Myocardial Infarction Research 18
- Antiplatelet Therapy and Cardiovascular Diseases 16
- Immunology and Allergy top 2%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 16
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- Asthma and respiratory diseases 11
- Co-authors
- Martin WeigertMarko RadicMark J. ShlomchikHua ShanRobert E. JordanDavid S. PisetskyAnn Marshak‐RothsteinLakshmi Damaraju
- Journals
- Circulation (8 papers)The Journal of Experimental Medicine (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Mary Ann Mascelli
64 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Internal Medicine 331
- Immunology 1.8k
- Hematology 722
- Cardiology and Cardiovascular Medicine 1.0k
- Immunology and Allergy 220
Countries citing papers authored by Mary Ann Mascelli
This map shows the geographic impact of Mary Ann Mascelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Mascelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Mascelli more than expected).
Fields of papers citing papers by Mary Ann Mascelli
This network shows the impact of papers produced by Mary Ann Mascelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Mascelli. The network helps show where Mary Ann Mascelli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Ann Mascelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Determination of optimal dosing of rhIGF-1/rhIGFBP-3 to establish and maintain physiological intrauterine serum IGF-1 levels in preterm infants | 2016 | 1 |
| 3 | 2012 | 22 | |
| 4 | 2011 | 104 | |
| 5 | 2009 | 4 | |
| 6 | 2008 | 49 | |
| 7 | 2007 | 149 | |
| 8 | 2006 | 168 | |
| 9 | A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis. | 2006 | 17 |
| 10 | 2004 | 212 | |
| 11 | 2004 | 31 | |
| 12 | 2003 | 36 | |
| 13 | 2000 | 34 | |
| 14 | 1998 | 2 | |
| 15 | 1996 | 3 | |
| 16 | 1992 | 8 | |
| 17 | 1991 | 196 | |
| 18 | Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.breakdown → | 1990 | 571 |
| 19 | 1989 | 59 | |
| 20 | 1988 | 4 |
About Mary Ann Mascelli
Mary Ann Mascelli is a scholar working on Internal Medicine, Hematology and Immunology, having authored 64 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (18 papers), Heparin-Induced Thrombocytopenia and Thrombosis (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Platelet Disorders and Treatments (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Asthma and respiratory diseases (11 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). The work is most often cited by research in Internal Medicine (331 citations), Immunology (1.8k citations) and Hematology (722 citations). Mary Ann Mascelli has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Martin Weigert, Marko Radic, Mark J. Shlomchik, Hua Shan, Robert E. Jordan, David S. Pisetsky, Ann Marshak‐Rothstein, Lakshmi Damaraju, Honghui Zhou and Charles Pendley. Their work appears in journals such as Circulation, The Journal of Experimental Medicine and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.